Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	NCOR2 AP2A2 RB1 TLE4 BCORL1 ATF7IP2 SMARCA4 IRAK2 SORBS1 DOK2 CNTLN STX7 NCK2 NPAT	4.18e-05	1160	70	14	GO:0030674
GeneOntologyMolecularFunction	small GTPase binding	PLEKHG1 RANBP10 GAPVD1 MYO9B ARHGEF7 EXPH5 TSC2	1.31e-04	321	70	7	GO:0031267
GeneOntologyMolecularFunction	transcription corepressor activity	NCOR2 RB1 TLE4 BCORL1 SMARCA4 NPAT	1.51e-04	229	70	6	GO:0003714
GeneOntologyMolecularFunction	molecular adaptor activity	NCOR2 AP2A2 RB1 TLE4 BCORL1 ATF7IP2 SMARCA4 IRAK2 SORBS1 DOK2 CNTLN STX7 NCK2 NPAT	2.20e-04	1356	70	14	GO:0060090
GeneOntologyMolecularFunction	GTPase binding	PLEKHG1 RANBP10 GAPVD1 MYO9B ARHGEF7 EXPH5 TSC2	2.64e-04	360	70	7	GO:0051020
GeneOntologyMolecularFunction	kinase binding	CYLD AP2A2 RB1 ARHGEF7 APC TNS2 SORBS1 DOK2 CNTLN CIT NCK2	5.19e-04	969	70	11	GO:0019900
GeneOntologyMolecularFunction	protein kinase binding	CYLD AP2A2 ARHGEF7 APC TNS2 SORBS1 DOK2 CNTLN CIT NCK2	8.90e-04	873	70	10	GO:0019901
GeneOntologyMolecularFunction	signaling receptor complex adaptor activity	SORBS1 DOK2 NCK2	9.00e-04	54	70	3	GO:0030159
GeneOntologyMolecularFunction	signaling adaptor activity	IRAK2 SORBS1 DOK2 NCK2	1.10e-03	129	70	4	GO:0035591
GeneOntologyMolecularFunction	enzyme regulator activity	PPP4R1 PLEKHG1 RANBP10 GAPVD1 DENND4A SERPINI1 MYO9B ARHGEF7 APC FNIP1 TSC2 CIT DCP1A	1.16e-03	1418	70	13	GO:0030234
GeneOntologyMolecularFunction	transcription factor binding	NCOR2 GRHL1 RB1 TLE4 ZNF516 PITX2 SMARCA4 CIT DCP1A	1.22e-03	753	70	9	GO:0008134
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	PLEKHG1 RANBP10 GAPVD1 DENND4A ARHGEF7	1.30e-03	231	70	5	GO:0005085
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	PLEKHG1 RANBP10 GAPVD1 DENND4A MYO9B ARHGEF7 TSC2	1.97e-03	507	70	7	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	PLEKHG1 RANBP10 GAPVD1 DENND4A MYO9B ARHGEF7 TSC2	1.97e-03	507	70	7	GO:0030695
GeneOntologyBiologicalProcess	negative regulation of intracellular signal transduction	CYLD NCOR2 ASH1L APC SMARCA4 FNIP1 TSC2 MINAR1 DOK2 CMYA5 CIT NCK2	1.16e-05	795	69	12	GO:1902532
Domain	cwf21	U2SURP SRRM2	1.38e-05	2	70	2	PF08312
Domain	mRNA_splic_Cwf21_dom	U2SURP SRRM2	1.38e-05	2	70	2	IPR013170
Domain	ZF_DAG_PE_1	MYO9B TNS2 CIT	1.78e-03	64	70	3	PS00479
Domain	ZF_DAG_PE_2	MYO9B TNS2 CIT	1.78e-03	64	70	3	PS50081
Domain	C1	MYO9B TNS2 CIT	1.86e-03	65	70	3	SM00109
Domain	PE/DAG-bd	MYO9B TNS2 CIT	1.95e-03	66	70	3	IPR002219
Domain	-	PLEKHG1 ARHGEF7 TNS2 DOK2 CIT DCP1A	3.44e-03	391	70	6	2.30.29.30
Domain	LisH	RANBP10 NPAT	4.91e-03	28	70	2	SM00667
Domain	LisH	RANBP10 NPAT	4.91e-03	28	70	2	IPR006594
Domain	LISH	RANBP10 NPAT	4.91e-03	28	70	2	PS50896
Domain	PH_dom-like	PLEKHG1 ARHGEF7 TNS2 DOK2 CIT DCP1A	5.21e-03	426	70	6	IPR011993
Domain	SPRY	RANBP10 CMYA5 RNF39	5.30e-03	94	70	3	PF00622
Domain	SPRY_dom	RANBP10 CMYA5 RNF39	5.30e-03	94	70	3	IPR003877
Domain	B30.2/SPRY	RANBP10 CMYA5 RNF39	5.46e-03	95	70	3	IPR001870
Domain	B302_SPRY	RANBP10 CMYA5 RNF39	5.46e-03	95	70	3	PS50188
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	CYLD PPP4R1 NCOR2 RB1 LMO7 MYO9B ZNF516 BCORL1 APC SORBS1 ZNF318 CNTLN NCK2	1.92e-10	588	71	13	38580884
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CYLD RANBP10 NCOR2 AP2A2 ATXN2 ARHGEF7 ZNF516 APC SMARCA4 TSC2 SORBS1 ZNF318 ARMCX4 CIT	7.88e-09	963	71	14	28671696
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	NCOR2 GAPVD1 TLE4 ZNF516 BCORL1 ATF7IP2 APC ZNF318 DCP1A NPAT	1.36e-08	418	71	10	34709266
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CYLD PLEKHG1 GAPVD1 DENND4A LMO7 EXPH5 APC FNIP1 TSC2 SORBS1 PPIP5K2 SRRM2 DCP1A	1.85e-08	861	71	13	36931259
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	NCOR2 GAPVD1 LMO7 TLE4 ZC3H13 ZNF516 ZBTB40 SMARCA4 ZNF318 SRRM2 CLASRP DCP1A	5.22e-08	774	71	12	15302935
Pubmed	Combinatorial CRISPR screen identifies fitness effects of gene paralogues.	AP2A2 RB1 SMARCA4 FNIP1 SRRM2 NCK2 DCP1A	1.11e-07	186	71	7	33637726
Pubmed	Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins.	GAPVD1 DENND4A LMO7 ZC3H13 APC TSC2 DCP1A	1.29e-07	190	71	7	15161933
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	CYLD PLEKHG1 GAPVD1 DENND4A AP2A2 LMO7 APC TSC2 SORBS1	3.19e-07	446	71	9	24255178
Pubmed	A genomic analysis of mouse models of breast cancer reveals molecular features of mouse models and relationships to human breast cancer.	RB1 APC SMARCA4	4.53e-07	8	71	3	25069779
Pubmed	Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.	GAPVD1 DENND4A LMO7 ARHGEF7 TSC2 SRRM2 DCP1A	9.35e-07	255	71	7	15324660
Pubmed	Human transcription factor protein interaction networks.	CYLD NCOR2 RB1 ATXN2 TLE4 ZNF516 BCORL1 ZBTB40 SMARCA4 ZNF318 SRRM2 CIT DCP1A NPAT	9.83e-07	1429	71	14	35140242
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	ZBTB37 NCOR2 GAPVD1 RB1 MYO9B TLE4 PITX2 ZBTB40 SMARCA4 LARP7 DCP1A	1.27e-06	857	71	11	25609649
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ZNF7 CYLD PPP4R1 LMO7 ASH1L APC SMARCA4 TSC2 SORBS1 ARMCX4 CMYA5 CIT MTUS2	1.78e-06	1285	71	13	35914814
Pubmed	RB localizes to DNA double-strand breaks and promotes DNA end resection and homologous recombination through the recruitment of BRG1.	RB1 SMARCA4	4.11e-06	2	71	2	27940962
Pubmed	Inactivation of conditional Rb by Villin-Cre leads to aggressive tumors outside the gastrointestinal tract.	RB1 APC	4.11e-06	2	71	2	16585182
Pubmed	The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest.	RB1 SMARCA4	4.11e-06	2	71	2	7923370
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	CYLD GAPVD1 DENND4A APC FNIP1 DCP1A	4.53e-06	209	71	6	36779422
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	ZC3H14 NCOR2 GAPVD1 AP2A2 LMO7 MYO9B U2SURP APC SRRM2 CIT LARP7 DCP1A	7.77e-06	1247	71	12	27684187
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	GAPVD1 LMO7 U2SURP SMARCA4 SORBS1 ZNF318 SRRM2 LARP7	9.05e-06	506	71	8	30890647
Pubmed	BRG1 is required for formation of senescence-associated heterochromatin foci induced by oncogenic RAS or BRCA1 loss.	RB1 SMARCA4	1.23e-05	3	71	2	23438604
Pubmed	The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16INK4a.	RB1 SMARCA4	1.23e-05	3	71	2	19149898
Pubmed	Human X chromosome exome sequencing identifies BCORL1 as contributor to spermatogenesis.	BCORL1 ARMCX4	1.23e-05	3	71	2	32376790
Pubmed	Loss of Rb1 in the gastrointestinal tract of Apc1638N mice promotes tumors of the cecum and proximal colon.	RB1 APC	1.23e-05	3	71	2	18832169
Pubmed	Characterization of mammary tumors from Brg1 heterozygous mice.	RB1 SMARCA4	1.23e-05	3	71	2	17637742
Pubmed	Expression of the proliferating cell nuclear antigen and protein products of tumour suppressor genes in the human foetal testis.	RB1 APC	1.23e-05	3	71	2	14871261
Pubmed	Brg1 chromatin remodeling factor is involved in cell growth arrest, apoptosis and senescence of rat mesenchymal stem cells.	RB1 SMARCA4	1.23e-05	3	71	2	17666433
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	ZC3H14 NCOR2 ATXN2 U2SURP ZNF516 BCORL1 ZBTB40 SMARCA4 ZNF318 SRRM2 CIT	1.39e-05	1103	71	11	34189442
Pubmed	TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.	CCSAP ZC3H14 ATXN2 MYO9B TLE4 ZC3H13 ZNF318 SRRM2 NCK2 DCP1A	1.75e-05	922	71	10	27609421
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	NCOR2 GAPVD1 ATXN2 ZC3H13 ZNF318 SRRM2 DCP1A	1.76e-05	399	71	7	35987950
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	USP17L7 GAPVD1 RB1 ZC3H13 SCN3A BCORL1 MUC19 TSC2 PCDH17	1.87e-05	736	71	9	29676528
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CYLD PLEKHG1 TLE4 FNIP1 DISP2 SORBS1 SRRM2	1.99e-05	407	71	7	12693553
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ZC3H14 NCOR2 ATXN2 ZC3H13 U2SURP BCORL1 SMARCA4 ZNF318 SRRM2 NPAT	2.34e-05	954	71	10	36373674
Pubmed	BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines.	RB1 SMARCA4	2.46e-05	4	71	2	11085541
Pubmed	Brg1 is required to maintain colorectal cancer stem cells.	APC SMARCA4	2.46e-05	4	71	2	34415580
Pubmed	Whole chromosome instability caused by Bub1 insufficiency drives tumorigenesis through tumor suppressor gene loss of heterozygosity.	RB1 APC	4.09e-05	5	71	2	19962666
Pubmed	Protein Phosphatase 1 binds strongly to the retinoblastoma protein but not to p107 or p130 in vitro and in vivo.	RB1 SMARCA4	4.09e-05	5	71	2	12434308
Pubmed	Prohibitin requires Brg-1 and Brm for the repression of E2F and cell growth.	RB1 SMARCA4	4.09e-05	5	71	2	12065415
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	ZC3H14 GAPVD1 LMO7 MYO9B U2SURP SMARCA4 ZNF318 STX7 SRRM2 CIT	4.25e-05	1024	71	10	24711643
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	NCOR2 ATXN2 ARHGEF7 APC MTUS2 LARP7 DCP1A	5.31e-05	475	71	7	31040226
Pubmed	The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1.	AP2A2 ZC3H13 SRRM2 LARP7 CLASRP	5.33e-05	197	71	5	20811636
Pubmed	Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	CYLD AP2A2 LMO7 ZC3H13	5.39e-05	100	71	4	10048485
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	ZC3H14 GAPVD1 ZC3H13 U2SURP SMARCA4 ZNF318 SRRM2 LARP7	5.56e-05	653	71	8	22586326
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	PPP4R1 GAPVD1 DENND4A ATXN2 ARHGEF7 SMARCA4 TSC2 SORBS1 DOK2 CMYA5 SRRM2	5.58e-05	1284	71	11	17353931
Pubmed	USP1 deubiquitinates Akt to inhibit PI3K-Akt-FoxO signaling in muscle during prolonged starvation.	ARHGEF7 TSC2 CMYA5	6.03e-05	37	71	3	32133736
Pubmed	Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.	MUC19 MUC16	6.13e-05	6	71	2	19110483
Pubmed	Lysine acetylation targets protein complexes and co-regulates major cellular functions.	DENND4A TSC2 SRRM2	6.53e-05	38	71	3	19608861
Pubmed	Charting the landscape of tandem BRCT domain-mediated protein interactions.	ATXN2 TLE4 U2SURP CNTLN SRRM2 LARP7 CLASRP DCP1A	6.65e-05	670	71	8	22990118
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	CYLD GAPVD1 TLE4 ZC3H13 ASH1L ZBTB40 APC ZNF318 DCP1A NPAT	6.84e-05	1084	71	10	11544199
Pubmed	MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.	RB1 BCORL1 MUC19 SMARCA4 ZNF318 NPAT	6.90e-05	339	71	6	30415952
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	ARHGEF7 APC SORBS1 STX7 SRRM2 CIT	7.84e-05	347	71	6	17114649
Pubmed	Interaction network of human early embryonic transcription factors.	NCOR2 TLE4 ZNF516 BCORL1 PITX2 SMARCA4	8.35e-05	351	71	6	38297188
Pubmed	Tumor suppressor gene mutations in mice.	RB1 APC	8.57e-05	7	71	2	8982467
Pubmed	A calcium-dependent switch in a CREST-BRG1 complex regulates activity-dependent gene expression.	RB1 SMARCA4	8.57e-05	7	71	2	19081374
Pubmed	Insights into cancer from transgenic mouse models.	RB1 APC	8.57e-05	7	71	2	10341706
Pubmed	The protein interaction landscape of the human CMGC kinase group.	RB1 TLE4 ZNF516 APC SRRM2 LARP7 NCK2 CLASRP	8.58e-05	695	71	8	23602568
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	CYLD AP2A2 LMO7 ZBTB40 MINAR1	9.97e-05	225	71	5	12168954
Pubmed	Disruption of the Rb--Raf-1 interaction inhibits tumor growth and angiogenesis.	RB1 SMARCA4	1.14e-04	8	71	2	15485920
Pubmed	Grb4 and GIT1 transduce ephrinB reverse signals modulating spine morphogenesis and synapse formation.	ARHGEF7 NCK2	1.14e-04	8	71	2	17310244
Pubmed	Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3.	NCOR2 SMARCA4	1.47e-04	9	71	2	10944117
Pubmed	Independent SH2-binding sites mediate interaction of Dok-related protein with RasGTPase-activating protein and Nck.	DOK2 NCK2	1.47e-04	9	71	2	10428862
Pubmed	Interaction of Axl receptor tyrosine kinase with C1-TEN, a novel C1 domain-containing protein with homology to tensin.	TNS2 NCK2	1.47e-04	9	71	2	12470648
Pubmed	The SH2/SH3 adaptor Grb4 transduces B-ephrin reverse signals.	SORBS1 NCK2	1.47e-04	9	71	2	11557983
Pubmed	KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4.	ZC3H14 NCOR2 U2SURP SRRM2	1.49e-04	130	71	4	35545047
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	RANBP10 U2SURP SORBS1 TSEN2	1.49e-04	130	71	4	12421765
Pubmed	Automated yeast two-hybrid screening for nuclear receptor-interacting proteins.	NCOR2 PCDH17 CLASRP DCP1A	1.63e-04	133	71	4	15604093
Pubmed	Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry.	ARHGEF7 ZC3H13 DOK2 SRRM2	1.63e-04	133	71	4	15144186
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	NCOR2 RB1 ZNF516 BCORL1 APC SMARCA4	1.65e-04	398	71	6	35016035
Pubmed	EB1 acetylation by P300/CBP-associated factor (PCAF) ensures accurate kinetochore-microtubule interactions in mitosis.	APC MTUS2	1.83e-04	10	71	2	23001180
Pubmed	Cardiomyocyte DNA synthesis and binucleation during murine development.	RB1 TSC2	1.83e-04	10	71	2	8945939
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	GAPVD1 ATXN2 EXPH5 APC ZNF318	2.06e-04	263	71	5	34702444
Pubmed	ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.	RB1 APC TSC2	2.20e-04	57	71	3	23788249
Pubmed	90-kDa ribosomal S6 kinase is a direct target for the nuclear fibroblast growth factor receptor 1 (FGFR1): role in FGFR1 signaling.	TNS2 NCK2	2.23e-04	11	71	2	15117958
Pubmed	Targeting HIV transcription: the quest for a functional cure.	SMARCA4 LARP7	2.23e-04	11	71	2	25731772
Pubmed	Apc inhibition of Wnt signaling regulates supernumerary tooth formation during embryogenesis and throughout adulthood.	PITX2 APC	2.23e-04	11	71	2	19429790
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	ZNF7 ZBTB37 GRHL1 ZC3H13 ZNF516 PITX2 ASH1L ZNF318	2.40e-04	808	71	8	20412781
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	ZC3H14 ATXN2 LMO7 SMARCA4 LARP7	2.49e-04	274	71	5	34244482
Pubmed	PRDM paralogs antagonistically balance Wnt/β-catenin activity during craniofacial chondrocyte differentiation.	APC SMARCA4	2.68e-04	12	71	2	35132438
Pubmed	Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse.	APC TSC2	2.68e-04	12	71	2	19150975
Pubmed	Mouse models in tumor suppression.	RB1 APC	2.68e-04	12	71	2	9917000
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	ZC3H14 NCOR2 LMO7 ZC3H13 U2SURP BCORL1 SMARCA4 ZNF318 SRRM2 CLASRP	2.88e-04	1294	71	10	30804502
Pubmed	ZBTB20 is crucial for the specification of a subset of callosal projection neurons and astrocytes in the mammalian neocortex.	ZBTB37 TLE4 ZBTB40	2.97e-04	63	71	3	34351428
Pubmed	Targeted ubiquitination and degradation of G-protein-coupled receptor kinase 5 by the DDB1-CUL4 ubiquitin ligase complex.	AP2A2 MYO9B U2SURP SRRM2	3.00e-04	156	71	4	22952844
Pubmed	Dual Requirement of CHD8 for Chromatin Landscape Establishment and Histone Methyltransferase Recruitment to Promote CNS Myelination and Repair.	APC SMARCA4	3.16e-04	13	71	2	29920279
Pubmed	Genotype phenotype correlations in Israeli colorectal cancer patients.	RB1 APC	3.16e-04	13	71	2	15523694
Pubmed	Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2.	PPP4R1 NCOR2 ARHGEF7 SMARCA4	3.38e-04	161	71	4	32572027
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	RANBP10 GAPVD1 DENND4A AP2A2 RB1 LMO7 TSC2 PPIP5K2 CLASRP DCP1A	3.39e-04	1321	71	10	27173435
Pubmed	Baf60c is a nuclear Notch signaling component required for the establishment of left-right asymmetry.	PITX2 SMARCA4	3.68e-04	14	71	2	17210915
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PLEKHG1 RANBP10 NCOR2 MYO9B ZNF516 DISP2 TSC2 CIT NCK2	4.06e-04	1105	71	9	35748872
Pubmed	Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions.	RB1 APC SMARCA4	4.22e-04	71	71	3	28319113
Pubmed	PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.	ZC3H14 LMO7 ZC3H13 U2SURP SRRM2 LARP7	4.35e-04	477	71	6	31300519
Pubmed	A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells.	RB1 SORBS1 CLASRP	4.58e-04	73	71	3	22094256
Pubmed	A novel nuclear receptor corepressor complex, N-CoR, contains components of the mammalian SWI/SNF complex and the corepressor KAP-1.	NCOR2 SMARCA4	4.84e-04	16	71	2	11013263
Pubmed	Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα.	RANBP10 ATXN2 U2SURP LARP7	5.36e-04	182	71	4	32239614
Pubmed	Identification of RanBP 9/10 as interacting partners for protein kinase C (PKC) gamma/delta and the D1 dopamine receptor: regulation of PKC-mediated receptor phosphorylation.	RANBP10 SCN3A	5.48e-04	17	71	2	20395553
Pubmed	ASPM regulates symmetric stem cell division by tuning Cyclin E ubiquitination.	RB1 CIT	5.48e-04	17	71	2	26581405
Pubmed	Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort.	NCOR2 SMARCA4	5.48e-04	17	71	2	19183483
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	PPP4R1 CCSAP ZC3H14 GAPVD1 AP2A2 PITX2 SMARCA4 TSC2	5.88e-04	925	71	8	28986522
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC19 MUC16	6.16e-04	18	71	2	18834073
Pubmed	A Chimeric Egfr Protein Reporter Mouse Reveals Egfr Localization and Trafficking In Vivo.	PITX2 APC	6.16e-04	18	71	2	28494873
Pubmed	Identification and selected reaction monitoring (SRM) quantification of endocytosis factors associated with Numb.	AP2A2 SRRM2	6.16e-04	18	71	2	23211419
Interaction	YWHAH interactions	CYLD PLEKHG1 ZC3H14 GAPVD1 DENND4A LMO7 ARHGEF7 EXPH5 ZC3H13 APC FNIP1 TNS2 TSC2 SORBS1 PPIP5K2 SRRM2 DCP1A	1.94e-07	1102	71	17	int:YWHAH
Interaction	YWHAG interactions	CYLD PLEKHG1 GAPVD1 DENND4A LMO7 ARHGEF7 EXPH5 ZC3H13 APC FNIP1 TNS2 TSC2 SORBS1 CNTLN PPIP5K2 SRRM2 DCP1A	1.11e-06	1248	71	17	int:YWHAG
Interaction	HDAC1 interactions	PPP4R1 CCSAP NCOR2 GAPVD1 RB1 LMO7 TLE4 ZNF516 PITX2 APC SMARCA4 ZNF318 CIT LARP7 DCP1A NPAT	1.14e-06	1108	71	16	int:HDAC1
Interaction	CCDC6 interactions	CYLD PPP4R1 GAPVD1 LMO7 APC SORBS1 MTUS2 NCK2	7.32e-06	286	71	8	int:CCDC6
Interaction	YWHAB interactions	CYLD GAPVD1 DENND4A LMO7 ARHGEF7 EXPH5 APC TNS2 TSC2 SORBS1 CNTLN PPIP5K2 SRRM2 DCP1A	1.00e-05	1014	71	14	int:YWHAB
Interaction	NUP43 interactions	NCOR2 ZC3H13 ASH1L MUC19 APC SMARCA4 ZNF318 SRRM2 CIT LARP7 NPAT	1.10e-05	625	71	11	int:NUP43
Interaction	GSK3A interactions	CYLD ZC3H14 GAPVD1 DENND4A U2SURP APC FNIP1 SRRM2 DCP1A	3.54e-05	464	71	9	int:GSK3A
Interaction	SF3A1 interactions	CYLD ZC3H14 GAPVD1 U2SURP SMARCA4 ZNF318 SRRM2 CIT LARP7	3.97e-05	471	71	9	int:SF3A1
Interaction	BAG2 interactions	CYLD GAPVD1 EXPH5 TLE4 BCORL1 ZNF318 PPIP5K2 SRRM2 CIT LARP7	6.18e-05	622	71	10	int:BAG2
Interaction	DHX8 interactions	ZC3H14 ZC3H13 U2SURP ZNF318 SRRM2 CIT CLASRP	7.51e-05	292	71	7	int:DHX8
Interaction	KDM1A interactions	NCOR2 GAPVD1 RB1 TLE4 ZNF516 BCORL1 ATF7IP2 APC ZNF318 CIT DCP1A NPAT	1.01e-04	941	71	12	int:KDM1A
Interaction	YWHAE interactions	CYLD NCOR2 GAPVD1 DENND4A LMO7 ARHGEF7 EXPH5 APC TNS2 TSC2 SORBS1 CNTLN SRRM2 DCP1A	1.05e-04	1256	71	14	int:YWHAE
Interaction	PABPC1L interactions	CYLD CIT LARP7	1.15e-04	27	71	3	int:PABPC1L
Interaction	CLK3 interactions	ZC3H14 NCOR2 ZC3H13 SRRM2 LARP7 CLASRP	1.25e-04	220	71	6	int:CLK3
Interaction	TERF2IP interactions	ZC3H14 NCOR2 RB1 U2SURP SMARCA4 ZNF318 SRRM2 LARP7 NPAT	1.34e-04	552	71	9	int:TERF2IP
Interaction	PABPC5 interactions	ZC3H14 ATXN2 ZC3H13 U2SURP SRRM2	1.45e-04	142	71	5	int:PABPC5
Interaction	SFN interactions	CYLD GAPVD1 DENND4A LMO7 EXPH5 APC TSC2 SORBS1 SRRM2 DCP1A	1.49e-04	692	71	10	int:SFN
Interaction	RNF6 interactions	AP2A2 LMO7 TNS2 MTUS2	1.50e-04	76	71	4	int:RNF6
Interaction	ZYX interactions	CYLD LMO7 ARHGEF7 APC SORBS1 CIT DCP1A	1.58e-04	329	71	7	int:ZYX
Interaction	SYNE3 interactions	CYLD PLEKHG1 NCOR2 LMO7 EXPH5 APC SORBS1 ZNF318	1.65e-04	444	71	8	int:SYNE3
Interaction	PXN interactions	PLEKHG1 AP2A2 ARHGEF7 APC SORBS1 NCK2 DCP1A	1.73e-04	334	71	7	int:PXN
Interaction	KRT23 interactions	CYLD EXPH5 APC	1.75e-04	31	71	3	int:KRT23
Interaction	RBBP4 interactions	CYLD RB1 ASH1L SMARCA4 SRRM2 CIT LARP7 CLASRP NPAT	1.77e-04	573	71	9	int:RBBP4
Interaction	PHF21A interactions	GAPVD1 ZNF516 BCORL1 APC ZNF318 DCP1A NPAT	2.03e-04	343	71	7	int:PHF21A
GeneFamily	CD molecules\|Mucins	MUC19 MUC16	1.35e-03	21	47	2	648
GeneFamily	Ataxins\|Trinucleotide repeat containing	NCOR2 ATXN2	1.91e-03	25	47	2	775
GeneFamily	Guanylate cyclase receptors\|DENN/MADD domain containing	DENND4A FNIP1	1.91e-03	25	47	2	504
GeneFamily	Zinc fingers CCCH-type	ZC3H14 ZC3H13	3.73e-03	35	47	2	73
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	APC ARMCX4	5.58e-03	43	47	2	409
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PLEKHG1 ARHGEF7	1.28e-02	66	47	2	722
Coexpression	GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP	GRHL1 RB1 TLE4 ATF7IP2 ZBTB40 APC FNIP1	1.19e-06	200	71	7	M7417
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	GAPVD1 ARHGEF7 EXPH5 TLE4 ZNF318 PPIP5K2 LARP7 NPAT	1.53e-06	300	71	8	M8702
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	ZC3H14 NCOR2 GAPVD1 RB1 ATXN2 MYO9B ARHGEF7 TLE4 U2SURP APC PPIP5K2 NPAT	2.97e-06	856	71	12	M4500
Coexpression	DING_LUNG_CANCER_MUTATED_FREQUENTLY	RB1 APC IRAK2	4.12e-06	12	71	3	M16718
Coexpression	GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP	TFEC IRAK2 FNIP1	1.51e-05	18	71	3	M19133
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000	GAPVD1 SERPINI1 ATXN2 ARHGEF7 ZC3H13 BCORL1 ATF7IP2 ASH1L SMARCA4 FNIP1 ZNF318 SHCBP1L LARP7	1.70e-06	795	70	13	gudmap_developingGonad_e16.5_ovary_1000
ToppCell	NS-moderate-d_0-4-Epithelial\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PPP4R1 GAPVD1 LMO7 EXPH5 ATF7IP2 MUC16	8.06e-07	200	71	6	64462a18afca3c1a8548a857924b8166058bf958
ToppCell	Mild/Remission-B_naive-4\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	DENND4A LMO7 ZNF318 STX7 NCK2	7.51e-06	169	71	5	c3a6179a64589a370108fea809b157839347759c
ToppCell	droplet-Kidney-nan-18m-Epithelial-collecting_duct_principal_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZBTB37 EXPH5 BCORL1 PITX2 ARMCX4	9.14e-06	176	71	5	533d544852038c0612aacf87f4b1c88ff7aace82
ToppCell	B_cells-Naive_B_cells_\|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis	PLEKHG1 ARHGEF7 ZNF318 REM2 NCK2	9.66e-06	178	71	5	71ac2eca5cf13a91f86b80690748b0788392dcfc
ToppCell	(4)_B_cells-(4)_B_mantle\|(4)_B_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	TLE4 SCN3A ZNF318 STX7 NCK2	1.10e-05	183	71	5	21b7fb6482eb1d5d31a4029e47e0992e8ddc8e2c
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PLEKHG1 GRHL1 LMO7 CIT PCDH17	1.13e-05	184	71	5	102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7
ToppCell	COPD-Endothelial-VE_Capillary_A\|Endothelial / Disease state, Lineage and Cell class	PLEKHG1 LMO7 EXPH5 ATF7IP2 SORBS1	1.26e-05	188	71	5	1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51
ToppCell	BLOOD--(2)_B_cell-(2)_Naive_B_cells\|(2)_B_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RB1 SCN3A ZNF318 STX7 NCK2	1.32e-05	190	71	5	bde288cea27bbdc3ca05737a00fe30a0103a4c74
ToppCell	PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	PLEKHG1 GRHL1 LMO7 EXPH5 MUC16	1.39e-05	192	71	5	c15841f35e24d6ef6ce2a9a6dc62e66efdc3d9d5
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	PPP4R1 PLEKHG1 TFEC DENND4A MYO9B	1.43e-05	193	71	5	08696a99309f5b088692ddac8cca35413b5e810d
ToppCell	severe-B_cell\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PLEKHG1 SCN3A APC WEE2 STX7	1.50e-05	195	71	5	0fc3c605609c9e6bdea15d73c45def2188ae5fb1
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PLEKHG1 GRHL1 LMO7 RNF39 CIT	1.61e-05	198	71	5	af399569c718f5fd971d73a7926768c9311002a3
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PLEKHG1 GRHL1 LMO7 RNF39 CIT	1.61e-05	198	71	5	1408e02e053ad3406229bfe8189da03be6366e81
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	PPP4R1 PLEKHG1 DENND4A MYO9B	1.34e-04	163	71	4	6bed27d2f67a430a847da5eb47878d14b4949c45
ToppCell	droplet-Mammary_Gland-nan-21m-Epithelial-nan\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF7 PLEKHG1 MYO9B SHCBP1L	1.40e-04	165	71	4	7c771f22b58989572c939ed127e637ec28dc0dca
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PLEKHG1 SCN3A ZNF318 STX7	1.40e-04	165	71	4	fead3f2032f8fa5f7f0159a4434989b3d65debbb
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231\|Adult / Lineage, Cell type, age group and donor	PLEKHG1 GRHL1 LMO7 CIT	1.57e-04	170	71	4	269dee5abca9f6aa079f116f0d8f1d198604d9d4
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_TMEM233\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GRHL1 GLRA3 MUC19 PCDH17	1.60e-04	171	71	4	fdd96c6fe850bd10e1e0d0f18c4401f8348b7d2c
ToppCell	3'_v3-blood-Lymphocytic_B-Naive_B_cells\|blood / Manually curated celltypes from each tissue	PLEKHG1 SCN3A ZNF318 STX7	1.64e-04	172	71	4	f16f90d17feac1ee52fd513907b28456865fd31d
ToppCell	facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCSAP BCORL1 CNTLN PCDH17	1.72e-04	174	71	4	9d5dcd46cf346c381dea68ada6665f7fb68114a3
ToppCell	facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCSAP BCORL1 CNTLN PCDH17	1.72e-04	174	71	4	53cec5c666c45278a71c21dd9c62a052a97e0fdf
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LMO7 MYO9B MRC2 REM2	1.75e-04	175	71	4	12f5fd83c7710fc0c77406f765d9cbd133433b8b
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LMO7 TLE4 ASH1L SRRM2	1.87e-04	178	71	4	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	GRHL1 LMO7 CIT PCDH17	1.87e-04	178	71	4	f5ed4a6e3eb8056b1be1fb311021710c95bdf888
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GRHL1 LMO7 MUC16 CMYA5	1.91e-04	179	71	4	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	GRHL1 SERPINI1 GLRA3 RNF39	1.95e-04	180	71	4	b509c7d6bdfba672065fb722874bdc68de72ba1c
ToppCell	Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PLEKHG1 IRAK2 SORBS1 PCDH17	1.95e-04	180	71	4	d8ef44710a77ad0fc03243428e5e1dc4d41200cb
ToppCell	B_cells-Naive_B_cells_\|World / Immune cells in Kidney/Urine in Lupus Nephritis	PLEKHG1 SCN3A ZNF318 STX7	2.04e-04	182	71	4	63c3b63315276b66667d49fab09661ac320e7a36
ToppCell	COVID-19-Heart-CM_3\|Heart / Disease (COVID-19 only), tissue and cell type	LMO7 SORBS1 CMYA5 MTUS2	2.04e-04	182	71	4	287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PLEKHG1 SCN3A ZNF318 STX7	2.08e-04	183	71	4	dbc7ec66da5930c2bf4e0405937b054e04c22a34
ToppCell	Control-Endothelial-Endothelial-Activated_Alv_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PLEKHG1 TLE4 SORBS1 PCDH17	2.08e-04	183	71	4	e81c142770f44fd902b0631bc360c5b5339d4c75
ToppCell	wk_08-11-Epithelial-Proximal_epithelial-Proximal_secretory_progenitors\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	GRHL1 LMO7 EXPH5 MUC16	2.12e-04	184	71	4	fcb5dd4fb3fa79f3b6029fad32a474cacde35a3b
ToppCell	COPD-Endothelial-VE_Capillary_A\|COPD / Disease state, Lineage and Cell class	PLEKHG1 EXPH5 SORBS1 PCDH17	2.12e-04	184	71	4	5f4f7775d488ececf086c71441defecbee9d8a9c
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Adult / Lineage, Cell type, age group and donor	PLEKHG1 GRHL1 LMO7 CIT	2.17e-04	185	71	4	673f0c688ae6984bc8027df2da335787924f4137
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PLEKHG1 GRHL1 LMO7 CIT	2.17e-04	185	71	4	98b8ee42b89d97e4c9db01740e0c193503c68f2c
ToppCell	Control-Epithelial-Club\|Epithelial / Disease state, Lineage and Cell class	PLEKHG1 GRHL1 TLE4 RNF39	2.17e-04	185	71	4	6814b3c94c7558443c038a227b5c8563d2cfeac4
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	LMO7 SORBS1 CMYA5 MTUS2	2.17e-04	185	71	4	6baccb26f999145e51b91d94315bf8d4655bef31
ToppCell	Control-Endothelial-Endothelial-Alv_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PLEKHG1 TLE4 SORBS1 PCDH17	2.26e-04	187	71	4	ea9d34bcd3bd1f36745846309ede349773de501a
ToppCell	Adult-Epithelial-club_cell-D231\|Adult / Lineage, Cell type, age group and donor	PLEKHG1 GRHL1 SERPINI1 RNF39	2.26e-04	187	71	4	ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86
ToppCell	Smart-seq2-blood_(Smart-seq2)-lymphocytic-B_lymphocytic-naive_B_cell\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PLEKHG1 SCN3A ZNF318 STX7	2.26e-04	187	71	4	160e5f338537d90d50f863a1be801b1071ac7da7
ToppCell	Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PLEKHG1 TLE4 SORBS1 PCDH17	2.26e-04	187	71	4	97b2463fb37e7196dd2f92553acf8e7bc3ec40dd
ToppCell	normal-na-Lymphocytic_B-B_naive-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	PLEKHG1 RB1 SCN3A STX7	2.31e-04	188	71	4	ec72ba73b10c6f2ff39699b6b46b90a3e95a4c24
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PLEKHG1 SCN3A ZNF318 STX7	2.31e-04	188	71	4	d8decd9b5967873ca8320c2f9f07365f163c777f
ToppCell	Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)\|Striatum / BrainAtlas - Mouse McCarroll V32	CYLD CCSAP SCN3A REM2	2.31e-04	188	71	4	e34ea7014c5a059a7db38f78bd903cf02616ddd3
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	LMO7 SORBS1 CMYA5 MTUS2	2.35e-04	189	71	4	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PLEKHG1 SCN3A ZNF318 STX7	2.35e-04	189	71	4	e2bb5900d210386b7b74938e7a3636d0c7ba1bcf
ToppCell	Control-Endothelial-Endothelial-Alv_Gen_Intermediate\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PLEKHG1 TLE4 SORBS1 PCDH17	2.35e-04	189	71	4	5d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1
ToppCell	Adult-Epithelial-club_cell\|Adult / Lineage, Cell type, age group and donor	PLEKHG1 GRHL1 SERPINI1 RNF39	2.40e-04	190	71	4	756bff697d30aec56c0ebfca94295f084a15bf37
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PLEKHG1 SCN3A ZNF318 STX7	2.40e-04	190	71	4	112706d64ee73b55dcf76f33ca064ab1fc6ce87f
ToppCell	3'_v3-bone_marrow-Lymphocytic_B-Naive_B_cells\|bone_marrow / Manually curated celltypes from each tissue	PLEKHG1 SCN3A ZNF318 STX7	2.40e-04	190	71	4	3d45d5011305f13634013d9eeb98f235517dd54e
ToppCell	droplet-Fat-Scat-21m-Endothelial-endothelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLEKHG1 LMO7 SORBS1 PCDH17	2.40e-04	190	71	4	d3e46cf800a07ca9b01c78192962d223b9785d05
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	LMO7 SORBS1 CMYA5 MTUS2	2.40e-04	190	71	4	de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCell	COVID_vent-Lymphocytic-B_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	PLEKHG1 SCN3A ZNF318 STX7	2.40e-04	190	71	4	40b5e9e8f8fd8d84cb5b43e67b49267082348e9f
ToppCell	COVID_vent-Lymphocytic-B_cell-\|COVID_vent / Disease condition, Lineage, Cell class and subclass	PLEKHG1 SCN3A ZNF318 STX7	2.40e-04	190	71	4	a37a32dc1b931562a6660074e19d5598efc65284
ToppCell	droplet-Fat-Scat-21m-Endothelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLEKHG1 LMO7 SORBS1 PCDH17	2.40e-04	190	71	4	dd89ef1ecea20b2f6fbdc6cea4ca41b28b3ed822
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PLEKHG1 SCN3A ZNF318 STX7	2.40e-04	190	71	4	a7498fe55b7810c482291db782dc5282675d246a
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	LMO7 SORBS1 CMYA5 MTUS2	2.40e-04	190	71	4	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	LMO7 SORBS1 CMYA5 MTUS2	2.45e-04	191	71	4	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PLEKHG1 GRHL1 LMO7 EXPH5	2.45e-04	191	71	4	60ff989fe99d243a3d52955223680cdd1f1917a4
ToppCell	LA-03._Atrial_Cardiomyocyte\|LA / Chamber and Cluster_Paper	LMO7 SORBS1 CMYA5 MTUS2	2.45e-04	191	71	4	5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCell	Children_(3_yrs)-Epithelial-club_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PLEKHG1 GRHL1 LMO7 RNF39	2.45e-04	191	71	4	23776c7302cead3881b39127398f3b3e0d27885e
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PLEKHG1 SCN3A ZNF318 STX7	2.45e-04	191	71	4	b374676ac90572d65895052d46469906e2b6fd93
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PLEKHG1 DENND4A SCN3A STX7	2.50e-04	192	71	4	446c61c0d6ba89c619efe87ee495951299953981
ToppCell	10x5'-bone_marrow-Lymphocytic_B-Naive_B_cells\|bone_marrow / Manually curated celltypes from each tissue	PLEKHG1 SCN3A ZNF318 STX7	2.50e-04	192	71	4	fa99243ff028498c6a67d207a93e02c48e69cd42
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PLEKHG1 SCN3A ZNF318 STX7	2.50e-04	192	71	4	800edadd1d1ba6b7e0a0398030dd4b61c9c480c7
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	LMO7 SORBS1 CMYA5 MTUS2	2.55e-04	193	71	4	dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell	Epithelial-club_cell\|World / Lineage, Cell type, age group and donor	PLEKHG1 GRHL1 LMO7 RNF39	2.55e-04	193	71	4	2bdd09004fa433550958ec42ba4b06271a4aaf7c
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	RANBP10 GRHL1 DENND4A SORBS1	2.55e-04	193	71	4	305e15ee467826ee08b2617c69f250ad39c11b19
ToppCell	Control-Endothelial-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PLEKHG1 TLE4 SORBS1 PCDH17	2.55e-04	193	71	4	aff0649c73c634bc6ff0dc7759b4693a9236bf05
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_B-Naive_B_cells\|lymph-node_spleen / Manually curated celltypes from each tissue	PLEKHG1 SCN3A ZNF318 STX7	2.55e-04	193	71	4	eb497d62a45ad77b2578b03a84cb3edc83207be5
ToppCell	Control-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PLEKHG1 TLE4 SORBS1 PCDH17	2.55e-04	193	71	4	c5f9fe03e64c211d4bcd4959e5b32f14841e336a
ToppCell	COVID_non-vent-Lymphocytic-B_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	PLEKHG1 SCN3A ZNF318 STX7	2.55e-04	193	71	4	32d139f922cd19adc1cc1e0e9a828115be9945d6
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PLEKHG1 TLE4 SORBS1 PCDH17	2.55e-04	193	71	4	a3636c35ed25aabe2f1aba016c9fe125327bbfaf
ToppCell	normal-na-Lymphocytic_B-B_naive-female\|normal / PBMC cell types (v2) per disease, treatment status, and sex	PLEKHG1 SCN3A ZNF318 STX7	2.55e-04	193	71	4	dd199163fc13f3d411fe741cf003237064349e22
ToppCell	PCW_05-06-Epithelial-Epithelial_airway\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	PLEKHG1 GRHL1 LMO7 EXPH5	2.55e-04	193	71	4	af6ec2c2ba92aef3e41531c3c7215b3300437bd9
ToppCell	COVID-19-kidney-FLT1+PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	PLEKHG1 ARHGEF7 SORBS1 PCDH17	2.55e-04	193	71	4	479abb1cd2eb978b8a4fdb900069a6329fc8cade
ToppCell	COVID_non-vent-Lymphocytic-B_cell-\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	PLEKHG1 SCN3A ZNF318 STX7	2.55e-04	193	71	4	91955c3773c9729a96e82f240f06b072367970d9
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	RANBP10 GRHL1 DENND4A SORBS1	2.55e-04	193	71	4	dd376664906caccc9c2065f8e7a364509e18a5cc
ToppCell	severe_influenza-B_naive\|severe_influenza / disease group, cell group and cell class (v2)	PLEKHG1 SCN3A ATF7IP2 NCK2	2.60e-04	194	71	4	7c1e9ce5de3bb1657a67010de673c8bb60129cb6
ToppCell	droplet-Pancreas-Endocrine-21m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF516 SMARCA4 DISP2 SRRM2	2.60e-04	194	71	4	3a3ecedcdc7691cf21775818b598208fcb980c29
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_B-Naive_B_cells\|lymph-node_spleen / Manually curated celltypes from each tissue	PLEKHG1 SCN3A ZNF318 STX7	2.60e-04	194	71	4	20967afbadb3cf80ba9f4d7ebda4e64389252e70
ToppCell	severe-B_cell\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PLEKHG1 SCN3A APC WEE2	2.60e-04	194	71	4	2fee6083fb56b16d1f04fd0b92ec622fd26ba3fa
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PLEKHG1 ZNF318 STX7 SRRM2	2.60e-04	194	71	4	ff661419b697aef51a53fdeac8d37d870d65f491
ToppCell	droplet-Limb_Muscle-MUSCLE\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LMO7 ASH1L SORBS1 PCDH17	2.60e-04	194	71	4	e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCell	RA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	LMO7 SORBS1 CMYA5 MTUS2	2.60e-04	194	71	4	89812fb164065041357bb37a3c2d87028ec3de4e
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PPP4R1 PLEKHG1 DENND4A RB1	2.60e-04	194	71	4	d852aebf7a763b9a776c4570711f0c759f591910
ToppCell	PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	PLEKHG1 GRHL1 LMO7 EXPH5	2.60e-04	194	71	4	b19e16a76d7342ff9a665d19c9151652916f17d4
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	LMO7 SORBS1 CMYA5 MTUS2	2.60e-04	194	71	4	c3535f7cc0076653c72db582047cff053c322397
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF516 SMARCA4 DISP2 SRRM2	2.60e-04	194	71	4	0b023de48ed8a550d169bbe954881eb04bf4f981
ToppCell	ILEUM-inflamed-(2)_B_cell-(2)_Naive_B_cells\|(2)_B_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RB1 ZNF318 STX7 NCK2	2.60e-04	194	71	4	a89e67a40382600739be92e395bf47dd44aa4122
ToppCell	ASK452-Endothelial-Lymphatic\|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq	RANBP10 ZC3H14 SCN3A SLC24A1	2.65e-04	195	71	4	20f492299a684ac1b7dd1bbc36a533cd6f9a1c93
ToppCell	COVID-19-Heart-CM_1\|Heart / Disease (COVID-19 only), tissue and cell type	LMO7 SORBS1 CMYA5 MTUS2	2.65e-04	195	71	4	f1ef50331eda8f1239dba6ea970df4eaccf032f1
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PLEKHG1 DENND4A SCN3A STX7	2.65e-04	195	71	4	0c49d22c348aec6d8a1a976e7c88d0a3b48a4244
ToppCell	severe-Lymphocytic-B_cells_1\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	PLEKHG1 SCN3A ZNF318 STX7	2.65e-04	195	71	4	73e39005a597e13aea571ae6ae5824d1c7448b71
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	LMO7 SORBS1 CMYA5 MTUS2	2.65e-04	195	71	4	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-CFuPNs\|3_mon / Sample Type, Dataset, Time_group, and Cell type.	SERPINI1 LMO7 TLE4 PCDH17	2.65e-04	195	71	4	574354ef4bcefeb9856b65d19bb92e2cffe5dc7a
ToppCell	Influenza_Severe-B_naive\|Influenza_Severe / Disease group and Cell class	PLEKHG1 SCN3A ATF7IP2 NCK2	2.65e-04	195	71	4	a25516ed670c7738670ffbaa6f7cd167946f3825
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PLEKHG1 GRHL1 LMO7 RNF39	2.65e-04	195	71	4	dccc32fcf772e2504de7f663ef0a5bd8e23e92fc
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF516 ASH1L FNIP1 SRRM2	2.65e-04	195	71	4	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF516 ASH1L FNIP1 SRRM2	2.65e-04	195	71	4	7796ea9247f4c63762f0de8490fed08b9717fa23
Drug	Diloxanide furoate [3736-81-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A	RB1 ZC3H13 ZNF516 ZBTB40 DOK2 SRRM2 PCDH17	1.92e-06	187	71	7	5025_UP
Drug	Gallamine triethiodide [65-29-2]; Up 200; 4.4uM; HL60; HG-U133A	RANBP10 ATXN2 MYO9B MRC2 ZC3H13 ZBTB40 TSC2	2.91e-06	199	71	7	1375_UP
Drug	Netilmicin sulfate [56931-57-2]; Down 200; 2.8uM; MCF7; HT_HG-U133A	AP2A2 ARHGEF7 BCORL1 ATF7IP2 APC NCK2 NPAT	3.00e-06	200	71	7	6005_DN
Drug	Lasalocid sodium salt [25999-20-6]; Down 200; 6.6uM; PC3; HT_HG-U133A	NCOR2 AP2A2 LMO7 MRC2 TLE4 APC	3.02e-05	192	71	6	6639_DN
Drug	radicicol; Up 200; 0.1uM; PC3; HG-U133A	GAPVD1 SERPINI1 ZC3H13 ZBTB40 DCP1A NPAT	3.30e-05	195	71	6	449_UP
Drug	Chlorthalidone [77-36-1]; Down 200; 11.8uM; PC3; HT_HG-U133A	SERPINI1 MYO9B U2SURP ASH1L APC ZNF318	3.30e-05	195	71	6	7152_DN
Drug	Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; HL60; HT_HG-U133A	RANBP10 AP2A2 RB1 SMARCA4 SLC24A1 CIT	3.39e-05	196	71	6	6155_DN
Drug	Oxybenzone [131-57-7]; Down 200; 17.6uM; PC3; HT_HG-U133A	LMO7 MYO9B ZBTB40 APC ZNF318 SLC24A1	3.39e-05	196	71	6	6309_DN
Drug	Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; PC3; HT_HG-U133A	RB1 MYO9B MRC2 TLE4 ZBTB40 ST7L	3.39e-05	196	71	6	4673_UP
Drug	Paroxetine maleate [64006-44-6]; Down 200; 1uM; PC3; HT_HG-U133A	MYO9B ARHGEF7 U2SURP ZBTB40 SLC24A1 SRRM2	3.49e-05	197	71	6	4556_DN
Drug	TTNPB; Up 200; 0.1uM; PC3; HG-U133A	SERPINI1 MRC2 ZBTB40 ST7L DCP1A NPAT	3.49e-05	197	71	6	451_UP
Drug	Nicergoline; Down 200; 8.2uM; PC3; HT_HG-U133A	CYLD RANBP10 DENND4A AP2A2 LMO7 MYO9B	3.49e-05	197	71	6	5775_DN
Drug	Allantoin [97-59-6]; Up 200; 25.2uM; HL60; HT_HG-U133A	CYLD MRC2 ZBTB40 APC PCDH17 NPAT	3.49e-05	197	71	6	1842_UP
Drug	Gossypol [303-45-7]; Down 200; 7.8uM; MCF7; HT_HG-U133A	NCOR2 SERPINI1 AP2A2 MYO9B TLE4 ZBTB40	3.59e-05	198	71	6	4762_DN
Drug	Pargyline hydrochloride [306-07-0]; Down 200; 20.4uM; MCF7; HT_HG-U133A	MYO9B ARHGEF7 U2SURP BCORL1 APC NPAT	3.59e-05	198	71	6	7016_DN
Drug	Isoxicam [34552-84-6]; Down 200; 12uM; MCF7; HT_HG-U133A	AP2A2 MYO9B ARHGEF7 EXPH5 TLE4 ZBTB40	3.59e-05	198	71	6	7028_DN
Drug	Diazoxide [364-98-7]; Up 200; 17.4uM; MCF7; HT_HG-U133A	AP2A2 MYO9B MRC2 SORBS1 DOK2 SLC24A1	3.59e-05	198	71	6	2214_UP
Drug	Torsemide [56211-40-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A	RANBP10 MYO9B APC ZNF318 SLC24A1 SRRM2	3.59e-05	198	71	6	5476_DN
Drug	Guanethidine sulfate [60-02-6]; Down 200; 13.4uM; HL60; HG-U133A	ZC3H14 DENND4A ATXN2 SMARCA4 TSEN2 NPAT	3.69e-05	199	71	6	1554_DN
Drug	Zoxazolamine [61-80-3]; Up 200; 23.8uM; MCF7; HT_HG-U133A	RANBP10 MYO9B MRC2 ZC3H13 DOK2 PCDH17	3.69e-05	199	71	6	2625_UP
Drug	Bendroflumethiazide [73-48-3]; Up 200; 9.4uM; HL60; HT_HG-U133A	AP2A2 EXPH5 MRC2 CNTLN SLC24A1 PCDH17	3.69e-05	199	71	6	2555_UP
Drug	Vancomycin hydrochloride [1404-93-9]; Down 200; 2.6uM; MCF7; HT_HG-U133A	AP2A2 EXPH5 TLE4 U2SURP PITX2 TNS2	3.69e-05	199	71	6	2858_DN
Drug	Helveticoside [630-64-8]; Down 200; 7.4uM; HL60; HT_HG-U133A	ZNF7 ZC3H14 U2SURP SLC24A1 TSEN2	2.90e-04	186	71	5	2192_DN
Drug	0179445-0000 [211246-22-9]; Down 200; 10uM; PC3; HT_HG-U133A	DENND4A ATF7IP2 TNS2 SORBS1 SLC24A1	3.12e-04	189	71	5	3733_DN
Drug	2-propylpentanoic acid; Up 200; 10000uM; HL60; HG-U133A	CYLD RANBP10 SERPINI1 MYO9B NPAT	3.20e-04	190	71	5	410_UP
Drug	Lanatoside C [17575-22-3]; Down 200; 4uM; HL60; HT_HG-U133A	ZNF7 ZC3H14 U2SURP SLC24A1 TSEN2	3.20e-04	190	71	5	2193_DN
Drug	Digoxigenin [1672-46-4]; Down 200; 10.2uM; HL60; HT_HG-U133A	ZNF7 ZC3H14 U2SURP SLC24A1 TSEN2	3.20e-04	190	71	5	3060_DN
Drug	thioridazine hydrochloride; Down 200; 10uM; PC3; HT_HG-U133A	AP2A2 U2SURP SMARCA4 SLC24A1 SRRM2	3.28e-04	191	71	5	4454_DN
Drug	Strophantine octahydrate [11018-89-6]; Down 200; 5.4uM; HL60; HT_HG-U133A	ZNF7 ZC3H14 U2SURP ZNF318 STX7	3.28e-04	191	71	5	1302_DN
Drug	nortropanol	CYLD GLRA3	3.40e-04	9	71	2	CID000068147
Drug	Bisacodyl [603-50-9]; Down 200; 11uM; PC3; HT_HG-U133A	ZNF7 CYLD MYO9B U2SURP SRRM2	3.44e-04	193	71	5	4616_DN
Drug	Canrenoic acid potassium salt [2181-04-6]; Down 200; 10uM; MCF7; HT_HG-U133A	RB1 MYO9B ZNF516 ZBTB40 TNS2	3.44e-04	193	71	5	6783_DN
Drug	Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; PC3; HT_HG-U133A	NCOR2 RB1 LMO7 APC SORBS1	3.44e-04	193	71	5	6699_DN
Drug	Talampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; MCF7; HT_HG-U133A	U2SURP APC TSC2 STX7 SLC24A1	3.44e-04	193	71	5	7014_DN
Drug	Doxycycline hydrochloride [10592-13-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A	ARHGEF7 EXPH5 BCORL1 ZBTB40 APC	3.44e-04	193	71	5	3479_DN
Drug	Butirosin disulfate salt [51022-98-1]; Down 200; 5.4uM; MCF7; HT_HG-U133A	AP2A2 RB1 MYO9B APC TNS2	3.52e-04	194	71	5	6779_DN
Drug	Ethoxyquin [91-53-2]; Up 200; 18.4uM; MCF7; HT_HG-U133A	NCOR2 RB1 TLE4 ST7L SLC24A1	3.52e-04	194	71	5	3846_UP
Drug	Cinchonine [118-10-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A	CYLD RB1 MYO9B MRC2 ZBTB40	3.52e-04	194	71	5	2789_UP
Drug	Alexidine dihydrochloride [22573-93-9]; Down 200; 6.8uM; MCF7; HT_HG-U133A	AP2A2 MYO9B U2SURP PITX2 SRRM2	3.52e-04	194	71	5	4721_DN
Drug	Pindolol [13523-86-9]; Down 200; 16.2uM; MCF7; HT_HG-U133A	RANBP10 PITX2 APC TNS2 ZNF318	3.52e-04	194	71	5	2238_DN
Drug	Skimmianine [83-95-4]; Down 200; 15.4uM; HL60; HT_HG-U133A	DENND4A ARHGEF7 U2SURP BCORL1 APC	3.52e-04	194	71	5	2504_DN
Drug	phentolamine; Down 200; 11.5uM; MCF7; HT_HG-U133A_EA	ZBTB40 SLC24A1 CLASRP DCP1A NPAT	3.61e-04	195	71	5	1138_DN
Drug	Triflusal [322-79-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A	RB1 MYO9B EXPH5 APC NPAT	3.61e-04	195	71	5	2867_DN
Drug	Hecogenin [467-55-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A	TLE4 ZNF516 BCORL1 ASH1L ZBTB40	3.61e-04	195	71	5	3457_DN
Drug	Homosalate [118-56-9]; Down 200; 15.2uM; PC3; HT_HG-U133A	CYLD RANBP10 MYO9B U2SURP TSC2	3.61e-04	195	71	5	4533_DN
Drug	Mefenamic acid [61-68-7]; Down 200; 16.6uM; PC3; HT_HG-U133A	RANBP10 DENND4A EXPH5 U2SURP ASH1L	3.61e-04	195	71	5	5109_DN
Drug	Bicuculline (+) [485-49-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A	RB1 ZC3H13 APC CNTLN SLC24A1	3.61e-04	195	71	5	2796_UP
Drug	Quinacrine dihydrochloride dihydrate [6151-30-0]; Down 200; 7.8uM; MCF7; HT_HG-U133A	CYLD MYO9B U2SURP PITX2 APC	3.61e-04	195	71	5	3179_DN
Drug	Quinidine hydrochloride monohydrate [6151-40-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A	CYLD AP2A2 U2SURP PITX2 SRRM2	3.61e-04	195	71	5	3191_DN
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A_EA	AP2A2 MYO9B EXPH5 ZBTB40 TNS2	3.69e-04	196	71	5	1024_DN
Drug	Edrophonium chloride [116-38-1]; Down 200; 19.8uM; HL60; HG-U133A	RANBP10 DENND4A TLE4 U2SURP SRRM2	3.69e-04	196	71	5	2019_DN
Drug	Tetracycline hydrochloride [64-75-5]; Up 200; 8.4uM; PC3; HT_HG-U133A	NCOR2 TFEC AP2A2 MRC2 ZNF516	3.69e-04	196	71	5	5757_UP
Drug	Oxolinic acid [14698-29-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A	ZBTB40 APC TSC2 ZNF318 CIT	3.69e-04	196	71	5	5519_DN
Drug	Delcorine; Down 200; 8.4uM; MCF7; HT_HG-U133A	SERPINI1 AP2A2 APC DOK2 SLC24A1	3.69e-04	196	71	5	3613_DN
Drug	Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; PC3; HT_HG-U133A	MRC2 TLE4 U2SURP ASH1L APC	3.69e-04	196	71	5	4100_DN
Drug	Praziquantel [55268-74-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A	TLE4 BCORL1 ASH1L ZBTB40 APC	3.69e-04	196	71	5	7228_DN
Drug	Meclocycline sulfosalicylate [73816-42-9]; Down 200; 5.8uM; PC3; HT_HG-U133A	DENND4A AP2A2 LMO7 ATF7IP2 SRRM2	3.69e-04	196	71	5	6637_DN
Drug	Cetirizine dihydrochloride [83881-52-1]; Up 200; 8.6uM; PC3; HT_HG-U133A	MYO9B GLRA3 APC SLC24A1 PCDH17	3.69e-04	196	71	5	4231_UP
Drug	Triflupromazine hydrochloride [1098-60-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A	CYLD AP2A2 EXPH5 BCORL1 DCP1A	3.69e-04	196	71	5	1691_DN
Drug	Cefoperazone dihydrate; Down 200; 5.8uM; PC3; HT_HG-U133A	CYLD NCOR2 DENND4A APC ZNF318	3.69e-04	196	71	5	6323_DN
Drug	Deptropine citrate [2169-75-7]; Up 200; 7.6uM; HL60; HT_HG-U133A	RANBP10 NCOR2 MYO9B SMARCA4 SRRM2	3.69e-04	196	71	5	3144_UP
Drug	Moricizine hydrochloride [31883-05-3]; Up 200; 8.6uM; MCF7; HT_HG-U133A	AP2A2 EXPH5 APC ZNF318 CNTLN	3.69e-04	196	71	5	6000_UP
Drug	Ipratropium bromide [22254-24-6]; Up 200; 9.8uM; PC3; HT_HG-U133A	LMO7 ZNF516 APC CNTLN SLC24A1	3.78e-04	197	71	5	5823_UP
Drug	Meclocycline sulfosalicylate [73816-42-9]; Down 200; 5.8uM; MCF7; HT_HG-U133A	AP2A2 BCORL1 APC TNS2 SRRM2	3.78e-04	197	71	5	3277_DN
Drug	Methylatropine nitrate [52-88-0]; Down 200; 11uM; PC3; HT_HG-U133A	ZC3H14 AP2A2 ZBTB40 TSC2 ZNF318	3.78e-04	197	71	5	7253_DN
Drug	2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A	NCOR2 MYO9B U2SURP TNS2 NPAT	3.78e-04	197	71	5	5211_DN
Drug	Mebendazole [31431-39-7]; Down 200; 13.6uM; MCF7; HT_HG-U133A	DENND4A PITX2 ASH1L ZNF318 NPAT	3.78e-04	197	71	5	2300_DN
Drug	alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A	NCOR2 ZC3H13 APC ST7L SLC24A1	3.78e-04	197	71	5	5207_UP
Drug	Ribostamycin sulfate salt [53797-35-6]; Down 200; 7.2uM; MCF7; HT_HG-U133A	CYLD ZC3H14 AP2A2 U2SURP ZBTB40	3.78e-04	197	71	5	3444_DN
Drug	L(-)-vesamicol hydrochloride [112709-59-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A	CYLD NCOR2 ZNF318 SLC24A1 PCDH17	3.78e-04	197	71	5	6497_UP
Drug	Chloropyramine hydrochloride [6170-42-9]; Up 200; 12.2uM; MCF7; HT_HG-U133A	CYLD AP2A2 CNTLN SLC24A1 PCDH17	3.78e-04	197	71	5	3350_UP
Drug	Cefotiam hydrochloride; Down 200; 7.2uM; MCF7; HT_HG-U133A	CYLD U2SURP ASH1L TNS2 SRRM2	3.78e-04	197	71	5	5361_DN
Drug	(S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; MCF7; HT_HG-U133A	NCOR2 AP2A2 MRC2 BCORL1 APC	3.78e-04	197	71	5	3870_DN
Drug	Procyclidine hydrochloride [1508-76-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A	CYLD AP2A2 ZC3H13 SORBS1 SLC24A1	3.87e-04	198	71	5	3330_UP
Drug	Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; PC3; HT_HG-U133A	AP2A2 ATF7IP2 APC SMARCA4 TSC2	3.87e-04	198	71	5	6353_DN
Drug	Carteolol hydrochloride [51781-21-6]; Up 200; 12.2uM; PC3; HT_HG-U133A	TFEC MYO9B ZNF516 PITX2 PCDH17	3.87e-04	198	71	5	4096_UP
Drug	Meprylcaine hydrochloride [956-03-6]; Up 200; 14.8uM; PC3; HT_HG-U133A	AP2A2 RB1 PITX2 GLRA3 APC	3.87e-04	198	71	5	5723_UP
Drug	Nabumetone [42924-53-8]; Up 200; 17.6uM; MCF7; HT_HG-U133A	CYLD TLE4 ZNF318 DOK2 PCDH17	3.87e-04	198	71	5	6487_UP
Drug	Kawain [500-64-1]; Down 200; 17.4uM; HL60; HT_HG-U133A	MRC2 BCORL1 ATF7IP2 ZBTB40 APC	3.87e-04	198	71	5	2337_DN
Drug	Heptaminol hydrochloride [543-15-7]; Down 200; 22uM; PC3; HT_HG-U133A	SERPINI1 AP2A2 MYO9B BCORL1 SRRM2	3.87e-04	198	71	5	7313_DN
Drug	Etodolac [41340-25-4]; Down 200; 14uM; MCF7; HT_HG-U133A	ARHGEF7 EXPH5 TLE4 U2SURP ZBTB40	3.87e-04	198	71	5	7006_DN
Drug	Tolmetin sodium salt dihydrate [64490-92-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A	MYO9B EXPH5 ZBTB40 APC SRRM2	3.87e-04	198	71	5	3347_DN
Drug	CP-690334-01 [459212-38-5]; Up 200; 1uM; MCF7; HT_HG-U133A	CYLD SERPINI1 RB1 ZC3H13 MINAR1	3.87e-04	198	71	5	4383_UP
Drug	estradiol, USP; Up 200; 0.01uM; HL60; HT_HG-U133A	CYLD NCOR2 EXPH5 SORBS1 ST7L	3.87e-04	198	71	5	6200_UP
Drug	Phenethicillin potassium salt [132-93-4]; Up 200; 10uM; PC3; HT_HG-U133A	DENND4A RB1 MYO9B MRC2 SLC24A1	3.87e-04	198	71	5	5763_UP
Drug	Yohimbine hydrochloride [65-19-0]; Up 200; 10.2uM; MCF7; HT_HG-U133A	CYLD AP2A2 ASH1L APC NPAT	3.87e-04	198	71	5	2755_UP
Drug	Clioquinol [130-26-7]; Down 200; 13uM; MCF7; HT_HG-U133A	AP2A2 MYO9B ZC3H13 ZBTB40 APC	3.87e-04	198	71	5	5258_DN
Drug	Flumequine [42835-25-6]; Up 200; 15.4uM; PC3; HT_HG-U133A	NCOR2 GLRA3 APC SORBS1 SLC24A1	3.87e-04	198	71	5	5104_UP
Drug	Griseofulvin [126-07-8]; Up 200; 11.2uM; HL60; HT_HG-U133A	AP2A2 ARHGEF7 ZC3H13 BCORL1 SRRM2	3.87e-04	198	71	5	2332_UP
Drug	Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A	RANBP10 AP2A2 ZNF516 ZNF318 SRRM2	3.87e-04	198	71	5	7035_UP
Drug	Karakoline [39089-30-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A	NCOR2 LMO7 MRC2 GLRA3 MINAR1	3.87e-04	198	71	5	3638_UP
Drug	Chloroquine diphosphate [50-63-5]; Up 200; 7.8uM; HL60; HG-U133A	ZC3H13 U2SURP BCORL1 ZNF318 NPAT	3.87e-04	198	71	5	1719_UP
Drug	Isoxsuprine hydrochloride [579-56-6]; Up 200; 11.8uM; HL60; HG-U133A	CYLD NCOR2 MYO9B BCORL1 PCDH17	3.87e-04	198	71	5	1985_UP
Drug	Diflunisal [22494-42-4]; Up 200; 16uM; PC3; HT_HG-U133A	RB1 TLE4 SCN3A APC ST7L	3.96e-04	199	71	5	4210_UP
Drug	Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Up 200; 16.4uM; MCF7; HT_HG-U133A	NCOR2 TLE4 ZC3H13 DOK2 SLC24A1	3.96e-04	199	71	5	4810_UP
Drug	Chlorphensin carbamate [886-74-8]; Up 200; 16.2uM; HL60; HG-U133A	MYO9B EXPH5 ZBTB40 TSC2 DOK2	3.96e-04	199	71	5	1432_UP
Drug	Piretanide [55837-27-9]; Up 200; 11uM; MCF7; HT_HG-U133A	RB1 MYO9B MRC2 SORBS1 SLC24A1	3.96e-04	199	71	5	6828_UP
Drug	Proglumide [6620-60-6]; Up 200; 12uM; PC3; HT_HG-U133A	MYO9B MRC2 TLE4 ZC3H13 SLC24A1	3.96e-04	199	71	5	3780_UP
Drug	Epirizole [18694-40-1]; Up 200; 17uM; MCF7; HT_HG-U133A	NCOR2 RB1 MYO9B EXPH5 SCN3A	3.96e-04	199	71	5	5995_UP
Drug	Retrorsine [480-54-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A	CYLD AP2A2 RB1 APC ZNF318	3.96e-04	199	71	5	4946_UP
Disease	immunoglobulin superfamily DCC subclass member 4 measurement	DENND4A SLC24A1	5.52e-05	5	70	2	EFO_0801690
Disease	platelet component distribution width	NCOR2 TFEC GAPVD1 ATXN2 MYO9B U2SURP DOK2 ST7L NCK2	7.23e-05	755	70	9	EFO_0007984
Disease	Intellectual Disability	ZC3H14 SCN3A ASH1L ZBTB40 APC TSEN2 LARP7	9.20e-05	447	70	7	C3714756
Disease	cardiovascular disease	PLEKHG1 ATXN2 MYO9B PITX2 SMARCA4 SORBS1 ZNF318	1.06e-04	457	70	7	EFO_0000319
Disease	immature platelet fraction	PPP4R1 MYO9B SORBS1 ST7L	1.59e-04	114	70	4	EFO_0009187
Disease	diastolic blood pressure, alcohol drinking	PLEKHG1 SLC39A12 ATXN2 ST7L	1.82e-04	118	70	4	EFO_0004329, EFO_0006336
Disease	Carcinoma, Small Cell	RB1 SMARCA4	1.98e-04	9	70	2	C0262584
Disease	medulloblastoma (is_implicated_in)	APC TSC2	2.47e-04	10	70	2	DOID:0050902 (is_implicated_in)
Disease	Mental Retardation, Psychosocial	ZBTB40 APC TSEN2 LARP7	3.40e-04	139	70	4	C0025363
Disease	Profound Mental Retardation	ZBTB40 APC TSEN2 LARP7	3.40e-04	139	70	4	C0020796
Disease	Mental deficiency	ZBTB40 APC TSEN2 LARP7	3.40e-04	139	70	4	C0917816
Disease	Animal Mammary Neoplasms	RB1 MRC2 TLE4 APC	3.68e-04	142	70	4	C0024667
Disease	Mammary Carcinoma, Animal	RB1 MRC2 TLE4 APC	3.68e-04	142	70	4	C1257925
Disease	platelet crit	TFEC ATXN2 MYO9B EXPH5 TLE4 U2SURP ZNF318 ST7L NPAT	4.07e-04	952	70	9	EFO_0007985
Disease	receptive language perception, parental genotype effect measurement	PLEKHG1 MUC19	4.96e-04	14	70	2	EFO_0005686, EFO_0005939
Disease	Non-Small Cell Lung Carcinoma	CYLD RB1 APC SMARCA4	5.25e-04	156	70	4	C0007131
Disease	Ischemic stroke, tissue plasminogen activator measurement	ATXN2 PITX2	5.71e-04	15	70	2	EFO_0004791, HP_0002140
Disease	level of Sterol ester (27:1/18:1) in blood serum	SMARCA4 CLASRP	6.52e-04	16	70	2	OBA_2045195
Disease	Ischemic stroke, plasminogen activator inhibitor 1 measurement	ATXN2 PITX2	6.52e-04	16	70	2	EFO_0004792, HP_0002140
Disease	factor XI measurement, Ischemic stroke	ATXN2 PITX2	7.37e-04	17	70	2	EFO_0004694, HP_0002140
Disease	intellectual disability (implicated_via_orthology)	ZC3H14 RB1 ATF7IP2	7.64e-04	75	70	3	DOID:1059 (implicated_via_orthology)
Disease	reticulocyte count	DENND4A ATXN2 MYO9B U2SURP ASH1L ZBTB40 RNF39 STX7 TSEN2	7.93e-04	1045	70	9	EFO_0007986
Disease	hypertension	NCOR2 SLC39A12 ATXN2 MYO9B ZNF318	8.22e-04	307	70	5	EFO_0000537
Disease	factor VIII measurement, Ischemic stroke	ATXN2 PITX2	9.24e-04	19	70	2	EFO_0004630, HP_0002140
Disease	diastolic blood pressure, systolic blood pressure	RANBP10 SLC39A12 GAPVD1 ATXN2 MRC2 GLRA3 DCP1A	1.05e-03	670	70	7	EFO_0006335, EFO_0006336
Disease	Sarcoma	RB1 SMARCA4	1.13e-03	21	70	2	C1261473
Disease	mean arterial pressure	PLEKHG1 ATXN2 MYO9B TNS2 ZNF318 ST7L	1.19e-03	499	70	6	EFO_0006340
Disease	anxiety disorder (implicated_via_orthology)	SCN3A TSC2	1.24e-03	22	70	2	DOID:2030 (implicated_via_orthology)
Disease	Sjogren's syndrome (is_marker_for)	MUC19 MUC16	1.48e-03	24	70	2	DOID:12894 (is_marker_for)
Disease	breast cancer (implicated_via_orthology)	APC SMARCA4	1.61e-03	25	70	2	DOID:1612 (implicated_via_orthology)
Disease	mean arterial pressure, alcohol drinking	PLEKHG1 ATXN2 ST7L	1.66e-03	98	70	3	EFO_0004329, EFO_0006340
Disease	level of Sterol ester (27:1/18:2) in blood serum	SMARCA4 CLASRP	1.74e-03	26	70	2	OBA_2045194
Disease	level of Sterol ester (27:1/16:0) in blood serum	SMARCA4 CLASRP	1.74e-03	26	70	2	OBA_2045191
Disease	Hereditary Nonpolyposis Colorectal Neoplasms	APC SMARCA4	1.74e-03	26	70	2	C0009405
Disease	Pancreatic Neoplasm	RB1 APC TSC2	1.75e-03	100	70	3	C0030297
Disease	Malignant neoplasm of pancreas	RB1 APC TSC2	1.86e-03	102	70	3	C0346647
Disease	Nephrotic Syndrome	TNS2 NCK2	1.87e-03	27	70	2	C0027726
Disease	Sezary Syndrome	RB1 SMARCA4	1.87e-03	27	70	2	C0036920
Disease	Hereditary Nonpolyposis Colorectal Cancer	APC SMARCA4	2.16e-03	29	70	2	C1333990
Disease	Ischemic stroke, factor VII measurement	ATXN2 PITX2	2.16e-03	29	70	2	EFO_0004619, HP_0002140
Disease	diastolic blood pressure, unipolar depression	PLEKHG1 ATXN2	2.31e-03	30	70	2	EFO_0003761, EFO_0006336
Disease	Ischemic stroke, von Willebrand factor measurement	ATXN2 PITX2	2.31e-03	30	70	2	EFO_0004629, HP_0002140

Protein segments in the cluster

Peptide	Gene	Start	Entry
ESTNCSPTRKRSSSE	ASH1L	1676	Q9NR48
KRSRSLSPKSSFTDS	CNTLN	511	Q9NXG0
TPSKSRSASSEEASE	BCORL1	1461	Q5H9F3
RKPSDEEFASRKSTA	ARHGEF7	691	Q14155
QTRTRETDKSPTSTE	CCSAP	136	Q6IQ19
VTRSSDLERKASSPS	DCP1A	511	Q9NPI6
RRSPSFDTSTATSKL	DISP2	1171	A7MBM2
PSSRRKESSTPEEFS	CIT	1336	O14578
VSRPDDKDEATTASR	ARMCX4	1756	Q5H9R4
PSTVTDLEDTKRDRS	AP2A2	621	O94973
SGRSEARESKEVTTS	MTUS2	491	Q5JR59
DSKSISTPSARRDLA	DENND4A	1191	Q7Z401
DSIDSFETQRTPRKS	RB1	346	P06400
SEVRSLSSRSPKSQD	RANBP10	346	Q6VN20
SSTFKDPERASLRDS	PCDH17	876	O14917
VATKETDSARSRSAP	GLRA3	26	O75311
IIKAPSSRRFSEDSS	NPAT	1286	Q14207
SPRLRESSTSEKTSS	MUC16	5486	Q8WXI7
TKPTTTSSSERERDR	NCOR2	1786	Q9Y618
SSPRDTSAFFLETKE	DOK2	76	O60496
RDSESSPSDFSVSLK	NCK2	311	O43639
GTERRKEDTPTSSRT	SLC24A1	136	O60721
RSDLPTSSDSKDFST	IRAK2	166	O43187
SNRAVTPSSEAKDSR	ATXN2	736	Q99700
STSDDTDVREVSSRP	GAPVD1	746	Q14C86
TKTSVEESRTTRPSA	MUC19	6101	Q7Z5P9
DSTTFAKREDRVTTE	LMO7	846	Q8WWI1
RYSRSSSSPTEATEK	MRC2	1451	Q9UBG0
PSTTVFSRRSPSDKD	EXPH5	901	Q8NEV8
KRSSSEDAESLAPRS	LARP7	296	Q4G0J3
SSVKRTFPEDESSSR	FCAMR	436	Q8WWV6
RRTPDSTFSETFKEG	GRHL1	206	Q9NZI5
TRTIDDVPFKTSTDS	FNIP1	846	Q8TF40
SERTLARPFDETKSS	CMYA5	2791	Q8N3K9
RTTESPSRVFTEEAK	ATF7IP2	121	Q5U623
KSLTEISTDFDRSSP	CYLD	386	Q9NQC7
VFSTETDKPSAQDSR	SLC39A12	21	Q504Y0
TSETSFSLSKEAPRE	ISM1	56	B1AKI9
PENTRTFSFTKDDES	SERPINI1	196	Q99574
KSLFTRPSSRSLTEE	MINAR1	701	Q9UPX6
PTTESFEKSVREDAS	TSEN2	201	Q8NCE0
RSESDSSPDSKAKTR	SRRM2	1556	Q9UQ35
SSFSPDEERRTKVQD	PPP4R1	601	Q8TF05
SRVSGSFPEDSSKER	STX7	126	O15400
SSTPTTSTRSRDKDD	SMARCA4	1421	P51532
TSEPSRDSFVVSKAD	SHCBP1L	456	Q9BZQ2
EFTDSPESRKEAASS	PITX2	36	Q99697
DSFPKSESEDSVKRS	SCN3A	521	Q9NY46
SPSPKSERSERSERS	U2SURP	946	O15042
STKSSGSESDRSERP	APC	2421	P25054
KRSPSESSSESRSRS	CLASRP	301	Q8N2M8
SARSTRDDPSNKETA	ZNF516	736	Q92618
AKVARPTSSEVDRFS	ZBTB37	296	Q5TC79
QRDRDSIKSSSVSPS	TLE4	196	Q04727
PARSSSLKSSSERND	SORBS1	501	Q9BX66
RTVSEKFSPETASRR	ST7L	376	Q8TDW4
SVTDRRSFSKVPETL	REM2	196	Q8IYK8
SLSEKSPLSSETRFD	USP17L7	36	P0C7H9
SPAVSKESSRRSSFS	TFEC	326	O14948
KSARSSSFTSGEREP	WEE2	551	P0C1S8
REEAESTPSKSARDS	PLEKHG1	676	Q9ULL1
RSRKTATNDEESPLS	PPIP5K2	966	O43314
SARPEKRDSRVSTSS	ZC3H14	121	Q6PJT7
DSTSTQEKRRRSFPD	ZNF318	516	Q5VUA4
KESTRRQDTRSPTSA	TNS2	921	Q63HR2
ENTKTISDSTSRRPS	ZC3H13	11	Q5T200
APRTSKTDSTIRTEN	ZNF7	76	P17097
DTPEKDSFRARSTSL	TSC2	926	P49815
VRDVSAPSSETFRKE	ZBTB40	126	Q9NUA8
RRFEVPTSKSSNSED	RNF39	196	Q9H2S5
TPTEERRTSFSTSDV	MYO9B	1346	Q13459